Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
4QHSH2PCHBnES8ME